The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ek John Frederick since 2019.
This trader's CIK number is 1767921.
At the time of last reporting, Ek John Frederick was the CFO of Akoya Biosciences, Inc.. (stock ticker symbol AKYA).
Also see all insider trading activities at Akoya Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | AKYA | 20,000 | $100,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | GNMK | 0 | $0 | 18,475 | $263,084 | 50,449 | $0 |
| 2020 | GNMK | 0 | $0 | 103,722 | $1,363,933 | 6,216 | $0 |
| 2019 | GNMK | 0 | $0 | 13,468 | $85,296 | 0 | $0 |
1. Akoya Biosciences, Inc. (AKYA)
2. Genmark Diagnostics, Inc. (GNMK)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-12 | AKYA | Buy | 20,000 | 5.00 | 100,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-21 | GNMK | Option Ex | 50,449 | .00 | 0 |
| 2021-01-25 | GNMK | Sale | 18,475 | 14.24 | 263,084 |
| 2020-11-24 | GNMK | Sale | 1,418 | 13.17 | 18,675 |
| 2020-11-19 | GNMK | Sale | 1,637 | 13.85 | 22,672 |
| 2020-09-22 | GNMK | Sale | 41,196 | 13.82 | 569,328 |
| 2020-09-16 | GNMK | Sale | 5,723 | 12.98 | 74,284 |
| 2020-08-25 | GNMK | Sale | 1,515 | 14.14 | 21,422 |
| 2020-08-20 | GNMK | Sale | 2,591 | 15.69 | 40,652 |
| 2020-08-18 | GNMK | Sale | 28,307 | 15.98 | 452,345 |
| 2020-08-14 | GNMK | Sale | 5,070 | 15.97 | 80,967 |
| 2020-05-28 | GNMK | Sale | 1,460 | 9.52 | 13,899 |
| 2020-05-19 | GNMK | Sale | 1,648 | 10.46 | 17,238 |
| 2020-02-27 | GNMK | Sale | 1,040 | 3.51 | 3,650 |
| 2020-02-25 | GNMK | Sale | 516 | 3.81 | 1,965 |
| 2020-02-20 | GNMK | Sale | 8,848 | 3.80 | 33,622 |
| 2020-01-21 | GNMK | Option Ex | 6,216 | .00 | 0 |
| 2020-01-21 | GNMK | Sale | 2,753 | 4.80 | 13,214 |
| 2019-11-25 | GNMK | Sale | 1,420 | 5.43 | 7,710 |
| 2019-11-20 | GNMK | Sale | 489 | 5.55 | 2,713 |
| 2019-08-27 | GNMK | Sale | 1,439 | 6.03 | 8,677 |
| 2019-08-20 | GNMK | Sale | 510 | 6.25 | 3,187 |
| 2019-08-05 | GNMK | Sale | 1,890 | 5.87 | 11,094 |
| 2019-05-30 | GNMK | Sale | 924 | 6.60 | 6,098 |
| 2019-05-23 | GNMK | Sale | 501 | 6.85 | 3,431 |
| 2019-05-21 | GNMK | Sale | 495 | 6.83 | 3,380 |
| 2019-02-25 | GNMK | Sale | 5,205 | 6.79 | 35,341 |
| 2019-02-20 | GNMK | Sale | 595 | 6.16 | 3,665 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ek John Frederick (CFO of Akoya Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.